News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Chandler Park: Discussing FDA-Approved Chemoimmunotherapy for Bladder Cancer with Muhamed Baljevic
Chandler Park/LinkedIn
May 2, 2025, 20:38

Chandler Park: Discussing FDA-Approved Chemoimmunotherapy for Bladder Cancer with Muhamed Baljevic

Chandler Park, Advisory Dean and Clinical Professor at the University of Louisville School of Medicine, shared a post on LinkedIn:

“Loved joining my good friend Dr. Muhamed Baljevic from Vanderbilt-Ingram Cancer on stage as we discussed the new FDA-approved perioperative chemoimmunotherapy treatment that improves the cure rate for our bladder cancer patients at Cardinal Health Clinical Updates and Healthcare in Atlanta. It is a grear honor to have been one of the co-prinicipal investigators for this practice changing clinical study that becomes the new standard of care.”

Read further.

More posts featuring Chandler Park.

bladder cancer cancer Cardinal Health Chandler Park Muhamed Baljevic OncoDaily Oncology Vanderbilt-Ingram Cancer
Special Coverage
Blog
May 2, 2025, 20:38
Chandler Park: Discussing FDA-Approved Chemoimmunotherapy for Bladder Cancer with Muhamed Baljevic
Insight
May 2, 2025, 20:26
Susanna Fletcher Greer: A V Foundation Researcher May Have Found the End-all to B-ALL
Blog
May 2, 2025, 20:20
Zainab Shinkafi-Bagudu: 50 Girls to Benefit from Scholarships at Miva Open University
Blog
May 2, 2025, 20:07
Lisa Lacasse: Thanking Senators and Volunteers for Their Leadership in Advancing Cancer Research Funding
Blog
May 2, 2025, 20:06
Youth Cancer Europe organised a High-Level Roundtable in the Parliament of the Republic of Moldova
Blog
May 2, 2025, 19:54
Stanley Wabomba: Miriam Mutebi Highlights the Need for Greater African Inclusion in Oncology Trials
Blog
May 2, 2025, 19:51
Valerie Yang: A Pleasure Being on the Interviewer Selection Panel
Blog
May 2, 2025, 19:39
The 2nd National Cancer Summit in Kenya - National Cancer Institute of Kenya
Blog
May 2, 2025, 19:29
Martin Zapata Laguado: First Time in This Huge and Very Interesting Event at AUA25
Blog
May 2, 2025, 19:17
William Aird: Updated List of Neoplastic Conditions Linked to Polycythemia
Blog
May 2, 2025, 18:49
Penilla Gunther: Patient Organizations Got a Good Review of Tools From the EU
Science
May 2, 2025, 18:25
LOXHD1 Identified as Immunotherapy Target in Ewing Sarcoma - Parker Institute for Cancer Immunotherapy